Dr.ย Zengย Ying Lang
MB, National Supervisory Certification
Deputy Director, Oncology & Vascular Interventional Therapy
corporate_fareHumanity Hospital Xiamen, China
Zeng Ying Lang
MB, National Supervisory Certification
Dr. Zeng Ying Lang is Deputy Director of the Department of Oncology and Vascular Interventional Therapy at Humanity Hospital Xiamen, one of Fujian Province's leading tertiary oncology centres. With more than twenty years of clinical experience, he holds the 12th Nationally Certified Supervisory Qualification in interventional medicine and has previously served at the 174th Hospital.
Dr. Zeng's clinical practice is built around minimally invasive interventional approaches for oncological and vascular conditions. He has particular depth in personalised interventional therapy for all stages of hepatocellular carcinoma, including Yttrium-90 radioembolization for primary liver cancer and liver metastases. His vascular portfolio spans haemorrhagic disorder management, visceral artery aneurysm embolization, haemangioma and vascular malformation treatment, uterine fibroid and adenomyosis embolization, peripheral arterial occlusive disease, and lower extremity venous conditions. He is also experienced in the revision of dysfunctional haemodialysis access. Dr. Zeng holds multiple standing committee roles in the Fujian Medical Association and Fujian Anti-Cancer Association, reflecting his standing in the regional interventional medicine community.
CancerFax can coordinate medical-record review, consultation requests, and travel-related support for international patients seeking interventional oncology care at Humanity Hospital Xiamen.
Why Consider Dr. Zeng Ying Lang?
Dr. Zeng combines deep vascular interventional expertise with oncology-specific minimally invasive techniques, giving patients access to advanced liver-directed therapies including Yttrium-90 radioembolization at one of China's leading tertiary cancer centres.
Areas of Specialization
Minimally invasive interventional treatment for cancer and vascular conditions
Interventional Oncology
Minimally invasive tumour-directed treatments for hepatocellular carcinoma and liver metastases.
- arrow_rightY-90 TARE for all-stage hepatocellular carcinoma
- arrow_rightY-90 radioembolization for liver metastases
- arrow_rightSelective internal radiation therapy with SIR-Spheres or TheraSphere
- arrow_rightStage-appropriate interventional treatment planning for HCC
- arrow_rightCombination approaches with targeted therapy and immunotherapy
- arrow_rightMultidisciplinary case coordination for unresectable liver cancer
Vascular Interventional Therapy
Minimally invasive management of haemorrhagic, vascular, and structural conditions.
- arrow_rightEmbolization for visceral artery aneurysms
- arrow_rightManagement of haemorrhagic disorders via interventional approach
- arrow_rightUterine fibroid embolization (UAE) and adenomyosis management
- arrow_rightMinimally invasive treatment of haemangiomas and vascular malformations
- arrow_rightPeripheral arterial occlusive disease management
- arrow_rightLower extremity venous thrombosis and varicose vein treatment
- arrow_rightDysfunctional haemodialysis access revision
Procedures Performed
Interventional oncology and vascular procedures
Liver-Directed Tumour Therapy
Medical OncologyCatheter-based intra-arterial treatments targeting liver tumours, including radioembolization and embolization.
Vascular Embolization
Complex DiseaseEmbolization procedures for haemorrhage, aneurysms, and benign vascular conditions.
Vascular Anomaly Treatment
MultidisciplinaryMinimally invasive treatment of haemangiomas, vascular malformations, and peripheral vascular disease.
Second Opinion & Case Review
Second OpinionIndependent review of interventional oncology cases for international and complex referrals.
Research & Publications
Interventional oncology research and clinical contributions
Dr. Zeng practices at Humanity Hospital Xiamen, which conducts Phase IโIV clinical trials and participates in advanced liver-directed therapy research. A detailed publication list is available on request.
Education & Training
Dr. Zeng Ying Lang completed his medical training in China and holds the 12th Nationally Certified Supervisory Qualification in interventional medicine. Specific degree institution details are pending verification.
Clinical Experience
Dr. Zeng has over twenty years of clinical experience in interventional oncology and vascular intervention. He formerly served at the 174th Hospital before joining Humanity Hospital Xiamen, where he holds the position of Deputy Director in the Department of Oncology and Vascular Interventional Therapy.
Languages & International
Dr. Zeng Ying Lang consults in the following languages.
CancerFax can coordinate professional medical interpreter support for international patients consulting with Dr. Zeng.
CancerFax can coordinate professional medical interpreter support for English, Arabic, and other international patient languages.
Frequently Asked Questions About Dr. Zeng Ying Lang
CancerFax can coordinate medical-record review and consultation support for international patients seeking care from Dr. Zeng at Humanity Hospital Xiamen, subject to hospital availability and case acceptance. Humanity Hospital Xiamen treats patients from over 50 countries.
Dr. Zeng specialises in interventional treatment for hepatocellular carcinoma (liver cancer) at all stages and liver metastases. He also manages haemangiomas, vascular malformations, uterine fibroids, and adenomyosis, as well as peripheral arterial and venous vascular conditions through minimally invasive approaches.
Yttrium-90 (Y-90) radioembolization is a minimally invasive liver-directed treatment in which radioactive microspheres are delivered via catheter into the hepatic artery to irradiate tumours from within. Dr. Zeng performs Y-90 radioembolization for primary liver cancer and liver metastases at Humanity Hospital Xiamen, which is one of a limited number of centres in China offering this therapy.
Submit your medical reports โ including imaging, pathology, and treatment history โ through CancerFax using the Send Your Reports button. The CancerFax team will review the documents, prepare a structured case summary, and coordinate the next steps with Humanity Hospital Xiamen, subject to availability.
Yes. A second-opinion request for hepatocellular carcinoma or liver metastases can be submitted through CancerFax with the patient's imaging (CT, MRI, PET-CT), pathology, laboratory results, and prior treatment history. Dr. Zeng can assess suitability for Yttrium-90 radioembolization, TACE, or other interventional approaches. The consultation format and timeline depend on the hospital's availability.
Beyond liver cancer treatment, Dr. Zeng performs embolization for visceral artery aneurysms, haemorrhage management, uterine fibroid embolization (UAE), minimally invasive treatment of haemangiomas and vascular malformations, peripheral arterial occlusive disease intervention, lower extremity venous thrombosis and varicose vein management, and haemodialysis access revision.
Connect with Zeng Ying Lang Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.